These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


183 related items for PubMed ID: 8191874

  • 1. Selective techniques of apheresis in polyneuropathy associated with monoclonal gammopathy of undetermined significance.
    Siciliano G, Moriconi L, Gianni G, Richieri E, Vignocchi MG, Rossi B.
    Acta Neurol Scand; 1994 Feb; 89(2):117-22. PubMed ID: 8191874
    [Abstract] [Full Text] [Related]

  • 2. [Neurological manifestations of monoclonal gammopathies].
    Chassande B, Léger JM.
    Rev Prat; 1993 Feb 01; 43(3):314-6. PubMed ID: 8389055
    [Abstract] [Full Text] [Related]

  • 3. Comparison of IgM-MGUS and IgG-MGUS polyneuropathy.
    Simovic D, Gorson KC, Ropper AH.
    Acta Neurol Scand; 1998 Mar 01; 97(3):194-200. PubMed ID: 9531437
    [Abstract] [Full Text] [Related]

  • 4. Long-term clinical and neurophysiological follow-up of patients with peripheral, neuropathy associated with benign monoclonal gammopathy.
    Ponsford S, Willison H, Veitch J, Morris R, Thomas PK.
    Muscle Nerve; 2000 Feb 01; 23(2):164-74. PubMed ID: 10639606
    [Abstract] [Full Text] [Related]

  • 5. Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities.
    Notermans NC, Wokke JH, Lokhorst HM, Franssen H, van der Graaf Y, Jennekens FG.
    Brain; 1994 Dec 01; 117 ( Pt 6)():1385-93. PubMed ID: 7820574
    [Abstract] [Full Text] [Related]

  • 6. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance.
    Dyck PJ, Low PA, Windebank AJ, Jaradeh SS, Gosselin S, Bourque P, Smith BE, Kratz KM, Karnes JL, Evans BA.
    N Engl J Med; 1991 Nov 21; 325(21):1482-6. PubMed ID: 1658648
    [Abstract] [Full Text] [Related]

  • 7. Monoclonal gammopathy and neuropathy.
    Ramchandren S, Lewis RA.
    Curr Opin Neurol; 2009 Oct 21; 22(5):480-5. PubMed ID: 19625962
    [Abstract] [Full Text] [Related]

  • 8. [Acquired peripheral neuropathies associated with monoclonal gammopathy].
    Gajos A, Kieliś W, Szadkowska I, Chmielowska E, Niewodniczy A, Bogucki A.
    Neurol Neurochir Pol; 2007 Oct 21; 41(2):169-75. PubMed ID: 17530580
    [Abstract] [Full Text] [Related]

  • 9. Neuropathies associated with IgG and IgA monoclonal gammopathy.
    Nobile-Orazio E, Casellato C, Di Troia A.
    Rev Neurol (Paris); 2002 Oct 21; 158(10 Pt 1):979-87. PubMed ID: 12407307
    [Abstract] [Full Text] [Related]

  • 10. IgA monoclonal gammopathy of undetermined significance with peripheral neuropathy.
    Mehndiratta MM, Sen K, Tatke M, Bajaj BK.
    J Neurol Sci; 2004 Jun 15; 221(1-2):99-104. PubMed ID: 15178222
    [Abstract] [Full Text] [Related]

  • 11. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies.
    Latov N.
    Ann Neurol; 1995 May 15; 37 Suppl 1():S32-42. PubMed ID: 8968215
    [Abstract] [Full Text] [Related]

  • 12. Evaluation and treatment of patients with neuropathy and monoclonal gammopathy.
    Latov N.
    Semin Neurol; 1994 Jun 15; 14(2):118-22. PubMed ID: 7984826
    [No Abstract] [Full Text] [Related]

  • 13. Successful management of polyneuropathy associated with IgM gammopathy of undetermined significance with antibody-based immunoadsorption.
    Toepfer M, Schroeder M, Müller-Felber W, Lochmüller H, Sitter T, Pongratz D, Schiffl H.
    Clin Nephrol; 2000 May 15; 53(5):404-7. PubMed ID: 11305816
    [Abstract] [Full Text] [Related]

  • 14. Neuropathy associated with monoclonal gammopathies of undetermined significance.
    Gosselin S, Kyle RA, Dyck PJ.
    Ann Neurol; 1991 Jul 15; 30(1):54-61. PubMed ID: 1656848
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal gammopathy and neuropathy.
    Notermans NC.
    Curr Opin Neurol; 1996 Oct 15; 9(5):334-7. PubMed ID: 8894407
    [Abstract] [Full Text] [Related]

  • 16. [Successful treatment with rituximab in two cases of IgM-monoclonal gammopathy of undetermined significance (MGUS) neuropathy].
    Koike M, Sugimoto K, Tusui M, Yahata Y.
    Rinsho Ketsueki; 2012 Apr 15; 53(4):450-4. PubMed ID: 22687979
    [Abstract] [Full Text] [Related]

  • 17. [Neuropathy associated with dysglobulinemia and monoclonal gammopathy].
    Saito T.
    Nihon Rinsho; 1994 Nov 15; 52(11):2976-83. PubMed ID: 7996697
    [Abstract] [Full Text] [Related]

  • 18. Peripheral neuropathy with gammopathy responding to plasmapheresis.
    Frayne J, Stark RJ.
    Clin Exp Neurol; 1985 Nov 15; 21():195-200. PubMed ID: 3032483
    [Abstract] [Full Text] [Related]

  • 19. Paraproteinemic neuropathies.
    Rojas-García R, Gallardo E, Illa I.
    Presse Med; 2013 Jun 15; 42(6 Pt 2):e225-34. PubMed ID: 23618626
    [Abstract] [Full Text] [Related]

  • 20. Polyneuropathy associated with IgA monoclonal gammopathy of undetermined significance.
    Simmons Z, Bromberg MB, Feldman EL, Blaivas M.
    Muscle Nerve; 1993 Jan 15; 16(1):77-83. PubMed ID: 8380902
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.